Health Care & Life Sciences » Biotechnology | Dyadic International Inc.

Dyadic International Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
428.10
5,980.10
65,787.30
3,608.70
2,135.80
5,691.80
Depreciation, Depletion & Amortization
253.50
271.10
-
-
-
-
Other Funds
-
54.60
90.80
40.60
-
1,164.60
Funds from Operations
170.50
4,553.10
2,373.60
3,343.50
1,765.50
4,527.10
Changes in Working Capital
4,925.40
1,646.90
1,571.00
2,691.90
840.80
119.90
Net Operating Cash Flow
5,095.90
6,200.10
802.70
6,035.40
2,606.30
4,407.20
Capital Expenditures
406.10
350.30
-
-
-
Sale of Fixed Assets & Businesses
-
19.80
67,000.00
-
-
Purchase/Sale of Investments
-
-
12.60
42,556.00
103.00
Net Investing Cash Flow
414.10
252.60
66,834.50
42,556.00
103.00
Issuance/Reduction of Debt, Net
-
-
24.90
-
-
Net Financing Cash Flow
220.60
55.70
73.90
13,120.40
6,222.50
Net Change in Cash
4,902.30
6,396.90
66,105.70
61,711.80
8,467.90
Free Cash Flow
4,783.70
6,458.90
802.70
6,035.40
2,606.30
Change in Capital Stock
220.60
1.20
8.10
13,161.00
6,222.50
Exchange Rate Effect
-
-
-
-
257.90
Other Uses
8.00
77.90
178.10
-
-

About Dyadic International

View Profile
Address
140 Intracoastal Pointe Drive
Jupiter Florida 33477
United States
Employees -
Website http://www.dyadic.com
Updated 07/08/2019
Dyadic International, Inc. operates as a biotechnology company. It uses its patented and proprietary technologies for the discovery, development, manufacture, and sale of enzymes and other proteins for the bioenergy, biochemical, biopharmaceutical, and industrial enzyme industries. The company was founded by Mark A.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.